AgingResearch.News
Research Square

A Phase 2b randomized clinical trial of the oral p38α inhibitor neflamapimod in dementia with Lewy bodies (DLB)

By John-Paul Taylor, John J. Alam, Stephen N. Gomperts, Show 8 more authorsJames E. Galvin
Preprint: trial in peopleInterventions
Paper

The paper

John-Paul Taylor, John J. Alam, Stephen N. Gomperts, Show 8 more authorsJames E. Galvin

Newcastle University; University of Miami

Research Square, 14 Aug 2026, Preprint, not peer-reviewed

doi.org/10.21203/rs.3.rs-10623740/v1PubMed 42845560

Related